Next Article in Journal
Recent Advances in Synthesis of 4-Arylcoumarins
Next Article in Special Issue
Design, Synthesis, Anticancer Evaluation and Molecular Modeling of Novel Estrogen Derivatives
Previous Article in Journal
Synthesis and Characterization of Poly(Vinyl Alcohol)-Chitosan-Hydroxyapatite Scaffolds: A Promising Alternative for Bone Tissue Regeneration
Previous Article in Special Issue
Synthesis, Molecular Docking and Anticancer Activity of Diflunisal Derivatives as Cyclooxygenase Enzyme Inhibitors
Article Menu
Issue 10 (October) cover image

Export Article

Open AccessArticle
Molecules 2018, 23(10), 2416; https://doi.org/10.3390/molecules23102416

Design, Synthesis and Docking Studies of Novel Macrocyclic Pentapeptides as Anticancer Multi-Targeted Kinase Inhibitors

1
Pharmaceutical Chemistry Department, Drug Exploration & Development Chair (DEDC), College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia
2
Applied Organic Chemistry Department, National Research Centre, 12622 Dokki, Giza, Egypt
3
Department of Peptide Chemistry, National Research Centre, 12622 Dokki, Giza, Egypt
4
Department of Pharmaceutical Chemistry, Faculty of Pharmacy (Girls), Al-Azhar University, 11754 Cairo, Egypt
5
Bioproducts Research Department, Zoology Department, Faculty of Science, King Saud University, Riyadh 11451, Saudi Arabia
6
Chemistry of Natural and Microbial Products Department, National Research Centre, 12622 Dokki, Cairo, Egypt
*
Author to whom correspondence should be addressed.
Received: 5 September 2018 / Revised: 17 September 2018 / Accepted: 18 September 2018 / Published: 20 September 2018
Full-Text   |   PDF [2707 KB, uploaded 20 September 2018]   |  

Abstract

A series of macrocyclic pyrido-pentapeptide candidates 26 were synthesized by using N,N-bis-[1-carboxy-2-(benzyl)]-2,6-(diaminocarbonyl)pyridine 1a,b as starting material. Structures of the newly synthesized compounds were established by IR, 1H and 13C-NMR, and MS spectral data and elemental analysis. The in-vitro cytotoxicity activity was investigated for all compounds against MCF-7 and HepG-2 cell lines and the majority of the compounds showed potent anticancer activity against the tested cell lines in comparison with the reference drugs. Out of the macrocyclic pyrido-pentapeptide based compounds, 5c showed encouraging inhibitory activity on MCF-7 and HepG-2 cell lines with IC50 values 9.41 ± 1.25 and 7.53 ± 1.33 μM, respectively. Interestingly, 5c also demonstrated multitarget profile and excellent inhibitory activity towards VEGFR-2, CDK-2 and PDGFRβ kinases. Furthermore, molecular modeling studies of the compound 5c revealed its possible binding modes into the active sites of those kinases. View Full-Text
Keywords: macrocyclic pentapeptides; in vitro anticancer activity; multitarget; molecular modeling studies macrocyclic pentapeptides; in vitro anticancer activity; multitarget; molecular modeling studies
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Amr, A.E.-G.; Abo-Ghalia, M.H.; Moustafa, G.O.; Al-Omar, M.A.; Nossier, E.S.; Elsayed, E.A. Design, Synthesis and Docking Studies of Novel Macrocyclic Pentapeptides as Anticancer Multi-Targeted Kinase Inhibitors. Molecules 2018, 23, 2416.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top